iNtRON Biotechnology, Inc. (KOSDAQ:048530)
4,020.00
+205.00 (5.37%)
Jan 29, 2026, 3:30 PM KST
-27.70% (1Y)
| Market Cap | 123.23B |
| Revenue (ttm) | 5.56B -35.5% |
| Net Income | -6.29B |
| EPS | -197.47 |
| Shares Out | 30.65M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 100.00 (2.62%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 478,720 |
| Average Volume | 260,551 |
| Open | 3,780.00 |
| Previous Close | 3,815.00 |
| Day's Range | 3,690.00 - 4,050.00 |
| 52-Week Range | 2,895.00 - 5,700.00 |
| Beta | 0.02 |
| RSI | 74.73 |
| Earnings Date | Jan 22, 2026 |